Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A benign or malignant neoplasm that affects the meninges. The majority of the neoplasms arise from meningothelial cells and are called meningiomas. Non-meningothelial cell neoplasms include mesenchymal, non-meningothelial tumors, hemangiopericytomas, and melanocytic lesions.
Biomarker and diagnostic research for tumor of meninges has been reported in the published literature.
5 clinical trials registered, 2 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and biologic therapy. Pipeline includes 2 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04250545](https://clinicaltrials.gov/study/NCT04250545) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:33 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer |
PHASE1 |
National Cancer Institute (NCI) |
UNKNOWN |
[NCT03025256](https://clinicaltrials.gov/study/NCT03025256) | Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease | PHASE1 | M.D. Anderson Cancer Center | ACTIVE_NOT_RECRUITING |
[NCT06417710](https://clinicaltrials.gov/study/NCT06417710) | Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis | — | University of Zurich | RECRUITING |
[NCT04988009](https://clinicaltrials.gov/study/NCT04988009) | Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology | — | M.D. Anderson Cancer Center | RECRUITING |
[NCT06146010](https://clinicaltrials.gov/study/NCT06146010) | Non Interventional German Leptomeningeal Disease Register | — | University Hospital Tuebingen | UNKNOWN |
49 publications have been identified in PubMed for tumor of meninges. Research spans Basic Science / Preclinical (43%), Case Report / Case Series (18%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 21 | 43% |
Patient case studies | 9 | 18% |
Testing and diagnosis research | 8 | 16% |
Disease patterns and progression | 4 | 8% |
Clinical study results | 3 | 6% |
Research summaries | 2 | 4% |
New treatment approaches | 2 | 4% |
Yefet LS (2026). [PMID: 41206747](https://pubmed.ncbi.nlm.nih.gov/41206747/). *Neuro Oncol*. [Basic Science / Preclinical]
Landry AP (2026). [PMID: 41259653](https://pubmed.ncbi.nlm.nih.gov/41259653/). *Neuro-oncology*. [Diagnostic / Biomarker]
Aunan-Diop JS (2026). [PMID: 41319647](https://pubmed.ncbi.nlm.nih.gov/41319647/). *Journal of the mechanical behavior of biomedical materials*. [Basic Science / Preclinical]
Guerra L (2026). [PMID: 41734064](https://pubmed.ncbi.nlm.nih.gov/41734064/). *Cell reports*. [Basic Science / Preclinical]
Broechner A (2026). [PMID: 41267161](https://pubmed.ncbi.nlm.nih.gov/41267161/). *Journal of neuropathology and experimental neurology*. [Epidemiology / Natural History]
Shintaku M (2026). [PMID: 42082317](https://pubmed.ncbi.nlm.nih.gov/42082317/). *Neuropathology*. [Case Report / Case Series]
Aso T (2026). [PMID: 41589518](https://pubmed.ncbi.nlm.nih.gov/41589518/). *Diagnostic cytopathology*. [Case Report / Case Series]
Rahmanzade R (2026). [PMID: 42034799](https://pubmed.ncbi.nlm.nih.gov/42034799/). *Acta Neuropathol*. [Basic Science / Preclinical]
Shiraki Y (2026). [PMID: 41213602](https://pubmed.ncbi.nlm.nih.gov/41213602/). *Brain pathology (Zurich, Switzerland)*. [Gene Therapy / Novel Therapeutics]
Yan J (2026). [PMID: 41630000](https://pubmed.ncbi.nlm.nih.gov/41630000/). *Journal of medical case reports*. [Case Report / Case Series]